Back to Agenda
Session 1308: NEW COLLABORATION MODELS FOR HOSPITALS AND SMOs
Session Chair(s)
Li Yang
Deputy Director of Drug Clinical Trial Center
Peking University 3rd Hospital, China
This session will describe the future development of SMOs in China. A new model for collaboration between Hospital and SMO optimizes site performance and ensures the high quality of clinical trial. Achieving success in Site/SMO new collaboration, the traditional role of CRC has been changed into a practical site management and monitoring team. SMOs are also participating in patient recruitment to accelerate patient access in clinical trials. Panelists include speakers from both hospitals and SMOs, who will provide their perspectives and thoughts on the effective and efficient operational approaches to partnership management for site and SMOs.
Speaker(s)
The Future Development of SMO in China
Bin Li
Pfizer Investment Co., Ltd., China
Tianxun Wang
Rundo International Pharmaceutical Research & Development Co.,Ltd., China
The Roles of Clinical Research Coordinators (CRCs) in Clinical Trials
Xiuqin Wang, MD
Jiangsu Province Hospital, China
Vice Director of Scientific Research Dept.
Hongdong Wang
Beijing ASMO Medical Research Co., Ltd., China
Have an account?